Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Nov. 30, 2018
Aug. 31, 2018
Current    
Cash and cash equivalents $ 2,644,860 $ 1,727,184
Marketable Securities (Note 18) 71,018 10,151
Accounts and other receivables (Note 6) 214,866 265,751
Inventory (Note 7) 116,668 87,233
Prepaid expenses (Note 17) 183,430 193,732
Total Current Assets 3,230,842 2,284,051
Patents (Note 8) 189,924 146,538
Property & Equipment (Note 9) 123,448 1,237
Total Noncurrent Assets 313,372 147,775
TOTAL ASSETS 3,544,214 2,431,826
Current    
Accounts payable and accrued liabilities 108,284 35,785
Due to related parties (Note 14) 21,654 7,855
Total Current Liabilities 129,938 43,640
TOTAL LIABILITIES 129,938 43,640
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 77,120,421 common shares at November 30, 2018 and 75,533,471 common shares at August 31, 2018 77,120 75,533
Additional paid-in capital 23,807,329 22,095,682
Accumulated other comprehensive loss   (14,247)
Deficit (20,470,173) (19,768,782)
Total Stockholders' Equity 3,414,276 2,388,186
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,544,214 $ 2,431,826